Metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet — RxCUI 861783
RxNorm drug concept · Semantic clinical drug
RxCUI 861783
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861783
Official nameMetformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspioglitazone 15 MG / metFORMIN HCl 500 MG Oral Tablet
FDA products mapped10
Package NDCs mapped31
Reported Medicaid activity (SDUD)3,108 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Metformin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No, and that's actually one of the things that makes metformin different. It doesn't force your pancreas to produce more insulin. Instead, it works in three ways: it tells your liv...
- What exactly does metformin do — does it just push my pancreas to make more insulin?
- Stomach upset, nausea, and diarrhea are really common at the start, and they can be significant for some people. The good news is they usually improve as your body adjusts. Always...
- The stomach side effects sound rough — is there anything I can do about them?
🕸️ Concept Web — How Metformin hydrochloride 500 MG / pioglitazone 15... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
RxCUI 861783 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Metformin
6809IN -
Pioglitazone
33738IN -
Metformin / pioglitazone
607999MIN -
Metformin hydrochloride
235743PIN
-
Metformin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Actoplus Met
602411BN
-
Actoplus Met
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metformin / pioglitazone Oral Tablet
577093SCDF -
Metformin hydrochloride / pioglitazone Oral Tablet
2647189SCDFP -
Metformin / pioglitazone Oral Product
1161597SCDG -
Metformin / pioglitazone Pill
1161598SCDG -
Metformin hydrochloride / pioglitazone Oral Product
2661623SCDGP -
Metformin hydrochloride / pioglitazone Pill
2659523SCDGP -
Metformin / pioglitazone Oral Tablet [Actoplus Met]
731442SBDF -
Metformin hydrochloride / pioglitazone Oral Tablet [Actoplus Met]
2655947SBDFP - +5 more in this family
-
Metformin / pioglitazone Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metformin hydrochloride 500 MG
860974SCDC -
Pioglitazone 15 MG
332435SCDC -
Metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met]
861785SBD -
Metformin hydrochloride 500 MG / pioglitazone 15 MG [Actoplus Met]
861784SBDC
-
Metformin hydrochloride 500 MG
Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metformin hydrochloride 500 MG
SCDC · 860974 -
Pioglitazone 15 MG
SCDC · 332435 -
Metformin / pioglitazone Oral Tablet
SCDF · 577093 -
Metformin hydrochloride / pioglitazone Oral Tablet
SCDFP · 2647189 -
Metformin / pioglitazone Oral Product
SCDG · 1161597 -
Metformin / pioglitazone Pill
SCDG · 1161598 -
Metformin hydrochloride / pioglitazone Oral Product
SCDGP · 2661623 -
Metformin hydrochloride / pioglitazone Pill
SCDGP · 2659523
Brand-Name Concepts
-
Metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met]
SBD · 861785 -
Metformin hydrochloride 500 MG / pioglitazone 15 MG [Actoplus Met]
SBDC · 861784 -
Metformin / pioglitazone Oral Tablet [Actoplus Met]
SBDF · 731442 -
Metformin hydrochloride / pioglitazone Oral Tablet [Actoplus Met]
SBDFP · 2655947 -
Actoplus Met Oral Product
SBDG · 1169920 -
Actoplus Met Pill
SBDG · 1169923 -
Actoplus Met
BN · 602411
📦 FDA Products & Package NDCs
10 products · 31 package NDCs
31 package NDCs map to RxCUI 861783 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13668-0280-05 | 500 TABLET in 1 BOTTLE (13668-280-05) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0280-10 | 1000 TABLET in 1 BOTTLE (13668-280-10) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0280-33 | 180 TABLET in 1 BOTTLE (13668-280-33) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0280-60 | 60 TABLET in 1 BOTTLE (13668-280-60) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0280-74 | 100 TABLET in 1 CARTON (13668-280-74) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0281-05 | 500 TABLET in 1 BOTTLE (13668-281-05) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0281-33 | 180 TABLET in 1 BOTTLE (13668-281-33) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0281-49 | 750 TABLET in 1 BOTTLE (13668-281-49) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0281-60 | 60 TABLET in 1 BOTTLE (13668-281-60) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 13668-0281-74 | 100 TABLET in 1 CARTON (13668-281-74) | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | 2025-09-01 |
| 33342-0176-09 | 60 TABLET in 1 BOTTLE (33342-176-09) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0176-11 | 100 TABLET in 1 BOTTLE (33342-176-11) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0176-12 | 10 BLISTER PACK in 1 CARTON (33342-176-12) / 10 TABLET in 1... | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0176-44 | 1000 TABLET in 1 BOTTLE (33342-176-44) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0176-57 | 180 TABLET in 1 BOTTLE (33342-176-57) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0177-09 | 60 TABLET in 1 BOTTLE (33342-177-09) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0177-11 | 100 TABLET in 1 BOTTLE (33342-177-11) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0177-12 | 10 BLISTER PACK in 1 CARTON (33342-177-12) / 10 TABLET in 1... | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0177-44 | 1000 TABLET in 1 BOTTLE (33342-177-44) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 33342-0177-57 | 180 TABLET in 1 BOTTLE (33342-177-57) | Pioglitazone and metformin hydrochloride | Macleods Pharmaceuticals Limited | 2015-11-06 |
| 57237-0217-60 | 60 TABLET, FILM COATED in 1 BOTTLE (57237-217-60) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Pharma Holdings, Inc. | 2013-02-13 |
| 57237-0217-81 | 180 TABLET, FILM COATED in 1 BOTTLE (57237-217-81) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Pharma Holdings, Inc. | 2013-02-13 |
| 57237-0218-60 | 60 TABLET, FILM COATED in 1 BOTTLE (57237-218-60) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Pharma Holdings, Inc. | 2013-02-13 |
| 57237-0218-81 | 180 TABLET, FILM COATED in 1 BOTTLE (57237-218-81) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Pharma Holdings, Inc. | 2013-02-13 |
| 65862-0525-18 | 180 TABLET, FILM COATED in 1 BOTTLE (65862-525-18) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | 2013-02-13 |
| 65862-0525-60 | 60 TABLET, FILM COATED in 1 BOTTLE (65862-525-60) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | 2013-02-13 |
| 65862-0526-18 | 180 TABLET, FILM COATED in 1 BOTTLE (65862-526-18) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | 2013-02-13 |
| 65862-0526-60 | 60 TABLET, FILM COATED in 1 BOTTLE (65862-526-60) | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | 2013-02-13 |
| 71335-3019-01 | 180 TABLET in 1 BOTTLE (71335-3019-1) | Pioglitazone and metformin hydrochloride | Bryant Ranch Prepack | 2025-12-03 |
| 72162-2497-02 | 180 TABLET in 1 BOTTLE (72162-2497-2) | Pioglitazole and metformin hydrochloride | Bryant Ranch Prepack | 2025-05-15 |
| 72162-2497-06 | 60 TABLET in 1 BOTTLE (72162-2497-6) | Pioglitazole and metformin hydrochloride | Bryant Ranch Prepack | 2025-05-15 |
Observed labelers:
Macleods Pharmaceuticals Limited (10) ·
Torrent Pharmaceuticals Limited (10) ·
Aurobindo Pharma Limited (4) ·
Rising Pharma Holdings, Inc. (4) ·
Bryant Ranch Prepack (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.